Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients
Aneta Cymbaluk-Płoska,1 Anita Chudecka-Głaz,1 Ewa Pius-Sadowska,2 Agnieszka Sompolska-Rzechuła,3 Bogusław Machaliński,2 Anna Surowiec,1 Janusz Menkiszak1 1Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, 2Department of General Pathology, Pomeranian Medical U...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-06-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-importance-of-serum-he4-and-mmp2-levels-in-endometrial-cancer-peer-reviewed-article-OTT |
id |
doaj-0d30aaed9b8b439d97e944dc54972bc3 |
---|---|
record_format |
Article |
spelling |
doaj-0d30aaed9b8b439d97e944dc54972bc32020-11-24T22:57:35ZengDove Medical PressOncoTargets and Therapy1178-69302017-06-01Volume 103169317533459Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patientsCymbaluk-Ploska AChudecka-Głaz APius-Sadowska ESompolska-Rzechuła AMachaliński BSurowiec AMenkiszak JAneta Cymbaluk-Płoska,1 Anita Chudecka-Głaz,1 Ewa Pius-Sadowska,2 Agnieszka Sompolska-Rzechuła,3 Bogusław Machaliński,2 Anna Surowiec,1 Janusz Menkiszak1 1Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, 2Department of General Pathology, Pomeranian Medical University, 3Department of Statistics, West Pomeranian University of Technology, Szczecin, Poland Introduction: Endometrial cancer is the one of the most common cancers of the genital organ. HE4 and MMP2 are both proteins whose serum levels increase in endometrial cancer.Aim: To explore the diagnostic potential of the serum levels of HE4 and MMP2 in patients with endometrial cancer and benign endometrial diseases. To assess the relationship between the serum levels of HE4 and MMP2 and the typical prognostic factors in patients with endometrial cancer.Materials and methods: Included in the study was a group of 112 patients presenting with bleeding abnormalities at the Pomeranian Medical University in years 2012–2016. Serum HE4 concentrations were measured using the Elecsys Electrochemiluminescence Immunoassay (ECLIA). MMP2 concentrations were quantified in the serum using multiplex immunoassays.Results: We observed statistically significant differences in mean serum levels of HE4 and MMP2 between the group of endometrial cancer patients and the group of patients with no changes in the endometrium (P=0.002/0.003). The diagnostic potential of HE4 and MMP2 in differentiation of high (International Federation of Gynecology and Obstetrics [FIGO] III and IV) vs low (FIGO I and II) clinical stage of tumor and prediction of cellular differentiation grade (G1 vs G3) on the basis of the analysis of the area under the curve is, respectively, 0.86 and 0.82 for HE4 and 0.82 and 0.74 for MMP2. The HE4 marker was significantly more specific than MMP2 in every study group and amounted to 93% vs 86% in all patients included in the analysis, 94% vs 84% in pre-menopausal patients and 84% vs 79% in post-menopausal patients.Conclusion: HE4 and MMP2 are characterized by high specificity and may be useful as biomarkers in the diagnostics of endometrial cancer. When determined preoperatively, HE4 is correlated with the prognostic factors of endometrial cancer and may be helpful in the planning of individual treatment of endometrial cancer patients. Keywords: MMP2, HE4, endometrial cancer, staging https://www.dovepress.com/clinical-importance-of-serum-he4-and-mmp2-levels-in-endometrial-cancer-peer-reviewed-article-OTTMMP2HE4endometrial cancerstaging. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cymbaluk-Ploska A Chudecka-Głaz A Pius-Sadowska E Sompolska-Rzechuła A Machaliński B Surowiec A Menkiszak J |
spellingShingle |
Cymbaluk-Ploska A Chudecka-Głaz A Pius-Sadowska E Sompolska-Rzechuła A Machaliński B Surowiec A Menkiszak J Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients OncoTargets and Therapy MMP2 HE4 endometrial cancer staging. |
author_facet |
Cymbaluk-Ploska A Chudecka-Głaz A Pius-Sadowska E Sompolska-Rzechuła A Machaliński B Surowiec A Menkiszak J |
author_sort |
Cymbaluk-Ploska A |
title |
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients |
title_short |
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients |
title_full |
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients |
title_fullStr |
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients |
title_full_unstemmed |
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients |
title_sort |
clinical importance of serum he4 and mmp2 levels in endometrial cancer patients |
publisher |
Dove Medical Press |
series |
OncoTargets and Therapy |
issn |
1178-6930 |
publishDate |
2017-06-01 |
description |
Aneta Cymbaluk-Płoska,1 Anita Chudecka-Głaz,1 Ewa Pius-Sadowska,2 Agnieszka Sompolska-Rzechuła,3 Bogusław Machaliński,2 Anna Surowiec,1 Janusz Menkiszak1 1Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, 2Department of General Pathology, Pomeranian Medical University, 3Department of Statistics, West Pomeranian University of Technology, Szczecin, Poland Introduction: Endometrial cancer is the one of the most common cancers of the genital organ. HE4 and MMP2 are both proteins whose serum levels increase in endometrial cancer.Aim: To explore the diagnostic potential of the serum levels of HE4 and MMP2 in patients with endometrial cancer and benign endometrial diseases. To assess the relationship between the serum levels of HE4 and MMP2 and the typical prognostic factors in patients with endometrial cancer.Materials and methods: Included in the study was a group of 112 patients presenting with bleeding abnormalities at the Pomeranian Medical University in years 2012–2016. Serum HE4 concentrations were measured using the Elecsys Electrochemiluminescence Immunoassay (ECLIA). MMP2 concentrations were quantified in the serum using multiplex immunoassays.Results: We observed statistically significant differences in mean serum levels of HE4 and MMP2 between the group of endometrial cancer patients and the group of patients with no changes in the endometrium (P=0.002/0.003). The diagnostic potential of HE4 and MMP2 in differentiation of high (International Federation of Gynecology and Obstetrics [FIGO] III and IV) vs low (FIGO I and II) clinical stage of tumor and prediction of cellular differentiation grade (G1 vs G3) on the basis of the analysis of the area under the curve is, respectively, 0.86 and 0.82 for HE4 and 0.82 and 0.74 for MMP2. The HE4 marker was significantly more specific than MMP2 in every study group and amounted to 93% vs 86% in all patients included in the analysis, 94% vs 84% in pre-menopausal patients and 84% vs 79% in post-menopausal patients.Conclusion: HE4 and MMP2 are characterized by high specificity and may be useful as biomarkers in the diagnostics of endometrial cancer. When determined preoperatively, HE4 is correlated with the prognostic factors of endometrial cancer and may be helpful in the planning of individual treatment of endometrial cancer patients. Keywords: MMP2, HE4, endometrial cancer, staging |
topic |
MMP2 HE4 endometrial cancer staging. |
url |
https://www.dovepress.com/clinical-importance-of-serum-he4-and-mmp2-levels-in-endometrial-cancer-peer-reviewed-article-OTT |
work_keys_str_mv |
AT cymbalukploskaa clinicalimportanceofserumhe4andmmp2levelsinendometrialcancerpatients AT chudeckagłaza clinicalimportanceofserumhe4andmmp2levelsinendometrialcancerpatients AT piussadowskae clinicalimportanceofserumhe4andmmp2levelsinendometrialcancerpatients AT sompolskarzechułaa clinicalimportanceofserumhe4andmmp2levelsinendometrialcancerpatients AT machalinskib clinicalimportanceofserumhe4andmmp2levelsinendometrialcancerpatients AT surowieca clinicalimportanceofserumhe4andmmp2levelsinendometrialcancerpatients AT menkiszakj clinicalimportanceofserumhe4andmmp2levelsinendometrialcancerpatients |
_version_ |
1725650193633771520 |